Difference between revisions of "Sources"
Jump to navigation
Jump to search
(Created page with "Knowledge aggregation sites such as HemOnc.org could not exist without primary sources. We access primary sources through a variety of means, including subscription to eTOCs, ...") |
m (→E-mail Alerts) |
||
| Line 28: | Line 28: | ||
*[https://public.govdelivery.com/accounts/USFDA/subscriber/new?pop=t&topic_id=USFDA_24 FDA Oncology Drug Approvals] | *[https://public.govdelivery.com/accounts/USFDA/subscriber/new?pop=t&topic_id=USFDA_24 FDA Oncology Drug Approvals] | ||
*[http://www.researchtopractice.com/ Research to Practice] | *[http://www.researchtopractice.com/ Research to Practice] | ||
| + | |||
| + | [[Category:General reference pages]] | ||
Revision as of 21:49, 25 November 2014
Knowledge aggregation sites such as HemOnc.org could not exist without primary sources. We access primary sources through a variety of means, including subscription to eTOCs, conference proceedings, and customized e-mail alerts through PubMed and other sources. This is a list of sources that we use most frequently:
Journals
- Annals of Oncology Journal of the European Society for Medical Oncology (ESMO)
- Blood Journal of the American Society of Hematology (ASH)
- British Journal of Haematology The official journal of the British Society for Haematology
- Cancer Published on behalf of the American Cancer Society (ACS)
- Clinical Cancer Research
- Clinical Lymphoma, Myeloma & Leukemia
- Haematologica Journal of the European Hematology Association (EHA)
- Journal of Clinical Oncology Official journal of the American Society of Clinical Oncology (ASCO)
- Journal of Hematology & Oncology Official journal of the Chinese American Hematologist and Oncologist Network
- The Lancet
- The Lancet Oncology
- Leukemia
- Leukemia & Lymphoma
- The New England Journal of Medicine
- Seminars in Oncology
Conference Proceedings
- ASCO Annual Meeting Proceedings
- ASH Annual Meeting Abstracts
- EHA Abstract Book
- ESMO Scientific Meeting Reports